Agiliti Health (UHOS) 10-Q 8 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Aug. 08, 2016
Document and Entity Information
Entity Registrant Name	UNIVERSAL HOSPITAL SERVICES INC
Entity Central Index Key	886,171
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		1,000
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Accounts receivable, less allowance for doubtful accounts of $1,500 at June 30, 2016 and December 31, 2015	$ 76,423	$ 71,252
Inventories	8,500	8,506
Other current assets	6,672	5,834
Total current assets	91,595	85,592
Property and equipment:
Medical equipment	595,635	590,091
Property and office equipment	88,872	85,341
Accumulated depreciation	(484,656)	(462,818)
Total property and equipment, net	199,851	212,614
Other long-term assets:
Goodwill	336,595	336,595
Other intangibles, net	156,601	162,354
Other	1,668	420
Total assets	786,310	797,575
Current liabilities:
Current portion of long-term debt	5,185	4,867
Book overdrafts	9,469	6,444
Accounts payable	25,689	31,073
Accrued compensation	15,109	23,600
Accrued interest	18,650	18,742
Dividend payable		24
Other accrued expenses	15,988	14,564
Total current liabilities	90,090	99,314
Long-term debt, less current portion	684,173	682,591
Pension and other long-term liabilities	11,621	11,869
Deferred income taxes, net	53,079	52,959
Commitments and contingencies (Note 8)
Deficit
Common stock, $0.01 par value; 1,000 shares authorized, issued and outstanding at June 30, 2016 and December 31, 2015
Additional paid-in capital	243,413	241,833
Accumulated deficit	(288,450)	(283,066)
Accumulated other comprehensive loss	(7,795)	(8,165)
Total Universal Hospital Services, Inc. deficit	(52,832)	(49,398)
Noncontrolling interest	179	240
Total deficit	(52,653)	(49,158)	$ (57,174)	$ (48,747)
Total liabilities and deficit	$ 786,310	$ 797,575

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Consolidated Balance Sheets
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 1,500	$ 1,500
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	1,000	1,000
Common stock, shares issued	1,000	1,000
Common stock, shares outstanding	1,000	1,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenue
Medical equipment solutions	$ 74,940	$ 71,084	$ 155,170	$ 145,169
Clinical engineering solutions	25,464	24,784	51,042	49,179
Surgical services	17,214	16,421	33,532	31,427
Total revenues	117,618	112,289	239,744	225,775
Cost of Revenue
Cost of medical equipment solutions	33,213	31,053	71,494	62,331
Cost of clinical engineering solutions	20,644	20,041	40,668	39,271
Cost of surgical services	8,956	8,722	17,722	16,902
Medical equipment depreciation	16,077	15,501	31,247	33,635
Total costs of revenues	78,890	75,317	161,131	152,139
Gross margin	38,728	36,972	78,613	73,636
Selling, general and administrative	28,798	31,038	60,095	61,189
(Gain) on settlement	(2,750)	(5,718)	(2,750)	(5,718)
Operating income	12,680	11,652	21,268	18,165
Interest expense	13,061	13,249	26,130	26,559
Loss before income taxes and noncontrolling interest	(381)	(1,597)	(4,862)	(8,394)
Provision for income taxes	228	182	387	351
Consolidated net loss	(609)	(1,779)	(5,249)	(8,745)
Net income attributable to noncontrolling interest	75	95	135	220
Net loss attributable to Universal Hospital Services, Inc.	$ (684)	$ (1,874)	$ (5,384)	$ (8,965)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Consolidated Statements of Comprehensive Loss
Consolidated net loss	$ (609)	$ (1,779)	$ (5,249)	$ (8,745)
Other comprehensive income:
Gain on minimum pension liability, net of tax of $0	184	488	370	488
Total other comprehensive income	184	488	370	488
Comprehensive loss	(425)	(1,291)	(4,879)	(8,257)
Comprehensive income attributable to noncontrolling interest	75	95	135	220
Comprehensive loss attributable to Universal Hospital Services, Inc.	$ (500)	$ (1,386)	$ (5,014)	$ (8,477)

Consolidated Statements of Com6

Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Consolidated Statements of Comprehensive Loss
Gain on minimum pension liability, tax	$ 0	$ 0	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Consolidated net loss	$ (5,249)	$ (8,745)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	36,614	38,315
Asset impairment charges		1,703
Amortization of intangibles, deferred financing costs and bond premium	6,011	6,532
Provision for doubtful accounts	130	54
Provision for inventory obsolescence	86	225
Non-cash share-based compensation expense	1,514	1,140
Gain on sales and disposals of equipment	(1,863)	(2,522)
Deferred income taxes	120	108
Interest on note receivable	(3)
Changes in operating assets and liabilities:
Accounts receivable	(5,301)	(3,980)
Inventories	(80)	(393)
Other operating assets	(1,100)	669
Accounts payable	(1,338)	2,000
Other operating liabilities	(6,537)	5,119
Net cash provided by operating activities	23,004	40,225
Cash flows from investing activities:
Medical equipment purchases	(27,412)	(27,437)
Property and office equipment purchases	(2,083)	(2,433)
Proceeds from disposition of property and equipment	6,944	9,426
Issuance of note receivable from officer	(983)
Acquisition		(2,600)
Net cash used in investing activities	(23,534)	(23,044)
Cash flows from financing activities:
Proceeds under senior secured credit facility	75,700	63,900
Payments under senior secured credit facility	(74,500)	(75,900)
Payments of principal under capital lease obligations	(2,944)	(4,154)
Payment of deferred financing costs	(97)
Holdback payment related to acquisition	(500)
Distributions to noncontrolling interests	(196)	(240)
Contributions from new members to limited liability companies		70
Dividend and equity distribution payments	(24)	(39)
Proceeds from exercise of parent company stock options	66
Change in book overdrafts	3,025	(818)
Net cash provided by (used in) financing activities	530	(17,181)
Supplemental cash flow information:
Interest paid	25,926	26,151
Income taxes paid	533	697
Non-cash activities:
Medical equipment purchases included in accounts payable (at end of period)	7,546	9,039
Capital lease additions	$ 3,484	$ 6,766

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2016
Basis of Presentation
Basis of Presentation	1. Basis of Presentation The interim consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared by Universal Hospital Services, Inc. (“we”, “our”, “us”, the “Company”, or “UHS”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted, pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s 2015 Annual Report on Form 10-K filed with the SEC. The interim consolidated financial statements presented herein as of June 30, 2016 , reflect, in the opinion of management, all adjustments necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. These adjustments are all of a normal, recurring nature. The results of operations for any interim period are not necessarily indicative of results for the full year. We are required to make estimates and assumptions about future events in preparing consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the amounts of assets, liabilities, revenues and expenses at the date of the unaudited consolidated financial statements. While we believe that our past estimates and assumptions have been materially accurate, our current estimates are subject to change if different assumptions as to the outcome of future events are made. We evaluate our estimates and judgments on an ongoing basis and predicate those estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances. We make adjustments to our assumptions and judgments when facts and circumstances dictate. Since future events and their effects cannot be determined with absolute certainty, actual results may differ from the estimates used in preparing the accompanying unaudited consolidated financial statements. A description of our significant accounting policies is included in our 2015 Annual Report on Form 10-K. There have been no material changes to these policies for the quarter ended June 30, 2016 . Principles of Consolidation The consolidated financial statements include the accounts of UHS and its 100% -owned subsidiary, UHS Surgical Services, Inc. (“Surgical Services”). In addition, in accordance with guidance issued by the Financial Accounting Standards Board (“FASB”), we have accounted for our equity investments in entities in which we are the primary beneficiary under the full consolidation method. All significant intercompany transactions and balances have been eliminated through consolidation. As the primary beneficiary, we consolidate the limited liability companies (“LLCs”) referred to in Note 10, Limited Liability Companies, as we effectively receive the majority of the benefits from such entities and we provide equipment lease guarantees for such entities.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2016
Recent Accounting Pronouncements
Recent Accounting Pronouncements	2. Recent Accounting Pronouncements Standards Adopted In November 2015, the FASB issued ASU No. 2015-17 Balance Sheet Classification of Deferred Taxes (“ASU 2015-17”) to simplify the presentation of deferred income taxes. ASU 2015-17 requires an entity with a classified balance sheet to present all deferred tax assets and liabilities as noncurrent. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016. Early adoption is permitted. We have elected to early adopt ASU 2015-17 as of December 31, 2015 and retrospectively applied ASU 2015-17 to all periods presented. In April 2015, the FASB issued ASU No. 2015-03 Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2015. We adopted ASU 2015-03 as of January 1, 2016 and retrospectively applied ASU 2015-03 to all periods presented. As a result, $10.3 million of deferred financing costs in other long-term assets were netted to long-term debt on the 2015 Consolidated Balance Sheets. In February 2015, the FASB issued ASU No. 2015-02 Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 changes the evaluation of whether limited partnerships (and similar legal entities) are variable interest entities (VIEs) and eliminates the presumption that a general partner should consolidate a limited partnership that is a voting interest entity. The new guidance also alters the analysis for determining when fees paid to a decision maker or service provider represent a variable interest in a VIE and how interests of related parties affect the primary beneficiary determination. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2015. The adoption of this standard does not have a material impact on our consolidated financial statements. Standards Not Yet Adopted In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“ASU 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in the GAAP when it becomes effective. The new standard is effective beginning after December 15, 2016 and interim periods within those years. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting. On July 9, 2015, the FASB approved a one -year deferral of the effective date for ASU 2014-09, but would permit companies to adopt the standard as of the original effective date. In August 2014, the FASB issued ASU No. 2014-15 Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”), which requires management to evaluate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern and whether or not it is probable that the entity will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. The new standard is effective beginning after December 15, 2016 and interim periods within those years. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on our consolidated financial statements. In July 2015, the FASB issued ASU No. 2015-11 Simplifying the Measurement of Inventory (“ASU 2015-11”). ASU 2015-03 changes the measurement principle for inventory from lower of cost or market to lower of cost and net realizable value for entities that do not measure inventory using the last in, first out or retail inventory method. The ASU also eliminates the requirement for these entities to consider replacement cost or net realizable value less an approximately normal profit margin when measuring inventory. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016. Early adoption is permitted. The adoption of this standard is not expected to have a material impact on our consolidated financial statements. In February 2016, the FASB issued ASU No. 2016-02 on Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 was issued to increase transparency and comparability among organizations by recognizing lease assets and lease liability on the balance sheet and disclosing key information about leasing arrangements. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2018. Early adoption is permitted. We are evaluating the effect that ASU 2016-02 will have on our consolidated financial statements and related disclosures. In March 2016, the FASB issued ASU No. 2016-08 Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”). ASU 2016-08 amends the principal versus agent guidance in ASU 2014-09, Revenue from Contracts with Customers , and clarifies that the analysis must focus on whether the entity has control of the goods and services before they are transferred to the customer. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2017. Early adoption is permitted but not before annual reporting periods beginning after December 15, 2016. We are evaluating the effect that ASU 2016-08 will have on our consolidated financial statements and related disclosures. In March 2016, the FASB issued ASU No. 2016-09 Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). ASU 2016-09 was issued as part of the FASB’s simplification initiative and intends to improve the accounting for share-based payment transactions. The areas for simplification in this ASU involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. Some of the areas for simplification apply only to nonpublic entities. The ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016. Early adoption is permitted in any interim or annual period provided that the entire ASU is adopted. If an entity early adopts the ASU in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The adoption of this standard is not expected to have a material impact on our consolidated financial statements. In April 2016, the FASB issued ASU No. 2016-10 Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing (“ASU 2016-10”). ASU 2016-10 amends the guidance in ASU 2014-09 about identifying performance obligations and accounting for licenses of intellectual property. The ASU is effective on adoption of ASU 2014-09. In May 2016, the FASB issued ASU No. 2016-12 Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2016-12 makes narrow-scope amendments to ASU 2014-09 and provides practical expedients to simplify the transition to the new standard and to clarify certain aspects of the standard. The ASU is effective on adoption of ASU 2014-09.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2016
Fair Value Measurements
Fair Value Measurements	3. Fair Value Measurements Financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 and December 31, 2015 are summarized in the following table by type of inputs applicable to the fair value measurements: Fair Value at June 30, 2016 Fair Value at December 31, 2015 (in thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Contingent Consideration $ — $ — $ — $ — $ — $ — $ $ A description of the inputs used in the valuation of assets and liabilities is summarized as follows: Level 1 — Inputs represent unadjusted quoted prices for identical assets or liabilities exchanged in active markets. Level 2 — Inputs include directly or indirectly observable inputs other than Level 1 inputs such as quoted prices for similar assets or liabilities exchanged in active or inactive markets; quoted prices for identical assets or liabilities exchanged in inactive markets; other inputs that are considered in fair value determinations of the assets or liabilities, such as interest rates and yield curves that are observable at commonly quoted intervals, volatilities, prepayment speeds, loss severities, credit risks and default rates; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 — Inputs include unobservable inputs used in the measurement of assets and liabilities. Management is required to use its own assumptions regarding unobservable inputs because there is little, if any, market activity in the assets or liabilities or related observable inputs that can be corroborated at the measurement date. Measurements of non-exchange traded derivative contract assets and liabilities are primarily based on valuation models, discounted cash flow models or other valuation techniques that are believed to be used by market participants. Unobservable inputs require management to make certain projections and assumptions about the information that would be used by market participants in pricing assets or liabilities. During 2012, we recorded a contingent consideration liability, in the form of an earn-out payment, related to our acquisitions. During 2015, we recorded a holdback liability related to our acquisition. The contingent consideration and holdback payments are based on achieving certain revenue results. The fair value of the liability was estimated using a discounted cash flow approach with significant inputs that are not observable in the market and thus represents a Level 3 fair value measurement . The significant inputs in the Level 3 measurement not supported by market activity included our assessments of expected future cash flows during the earn-out period, related to the assets acquired, appropriately discounted considering the uncertainties associated with the obligation, and calculated based on estimated revenues in accordance with the terms of the agreements. During the three months ended June 30, 2016 and 2015 , we paid $0 and $0.01 million, respectively, in earn-outs. During the six months ended June 30, 2016 and 2015 , we paid $0.5 and $0.02 million, respectively, in earn-outs and holdback. The assumptions used in preparing the discounted cash flow analysis included estimates of interest rates and the timing and amount of incremental cash flows. A reconciliation of the beginning and ending balance for the Level 3 measurement are as follows: (in thousands) Balance at December 31, 2015 $ Payments Balance at June 30, 2016 $ — Fair Value of Other Financial Instruments The Company considers that the carrying amount of financial instruments, including accounts receivable, accounts payable, accrued liabilities and senior secured credit facility, approximates fair value due to their short maturities. The fair value of our outstanding Original Notes and Add-on Notes (each as defined in Note 7, Long-Term Debt) as of June 30, 2016 and December 31, 2015 , based on the quoted market price for the same or similar issues of debt, which represents a Level 2 fair value measurement, is approximately: June 30, 2016 December 31, 2015 Carrying Fair Carrying Fair (in thousands) Value Value Value Value Original notes - 7.625% (1) $ $ $ $ Add-on notes - 7.625% (2) (1) The carrying value of the Original notes - 7.625% is net of unamortized deferred financing costs of $5.1 and $5.7 million as of June 30, 2016 and December 31, 2015 , respectively. (2) The carrying value of the Add-on notes - 7.625% % is net of unamortized deferred financing costs of $2.1 and $2.4 million as of June 30, 2016 and December 31, 2015 , respectively, and includes unamortized bond premium of $8.5 and $9.4 million as of June 30, 2016 and December 31, 2015 , respectively.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	6 Months Ended
	Jun. 30, 2016
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets	4. Goodwill and Other Intangible Assets Our goodwill as of June 30, 2016 and December 31, 2015 , by reporting segment, consists of the following: Medical Clinical Equipment Engineering Surgical (in thousands) Solutions Solutions Services Total Balance at December 31, 2015 $ $ $ $ Acquisition — — — — Balance at June 30, 2016 $ $ $ $ Our other intangible assets as of June 30, 2016 and December 31, 2015 consist of the following : June 30, 2016 December 31, 2015 Accumulated Accumulated (in thousands) Cost Amortization Impairment Net Cost Amortization Impairment Net Finite-life intangibles Customer relationship $ $ $ — $ $ $ $ — $ Supply agreement — — Non-compete agreements — — Total finite-life intangibles — — Indefinite-life intangibles Trade names — — Total intangible assets $ $ $ $ $ $ $ $ Total amortization expense related to intangible assets were $2.8 and $3.0 million for the three months ended June 30, 2016 and 2015 , respectively, and $5.8 and $6.1 million for the six months ended June 30, 2016 and 2015 , respectively. The estimated future amortization expense for identifiable intangible assets during the remainder of 2016 and the next five years is as follows: (in thousands) Remainder of 2016 $ 2017 2018 2019 2020 2021

Deficit

Deficit	6 Months Ended
	Jun. 30, 2016
Deficit
Deficit	5. Deficit The following tables represent changes in deficit that are attributable to our shareholders and noncontrolling interests for the six month periods ended June 30, 2016 and 2015 . Accumulated Additional Other Paid-in Accumulated Comprehensive Noncontrolling Total (in thousands) Capital Deficit Loss Interests Deficit Balance at December 31, 2015 $ $ $ $ $ Net (loss) income — — Other comprehensive income — — — Share-based compensation — — — Stock option exercised — — — Cash distributions to noncontrolling interests — — — Balance at June 30, 2016 $ $ $ $ $ Accumulated Additional Other Paid-in Accumulated Comprehensive Noncontrolling Total (in thousands) Capital Deficit Loss Interests Deficit Balance at December 31, 2014 $ $ $ $ $ Net (loss) income — — Other comprehensive income — — — Cash distributions to noncontrolling interests — — — Contributions from new members to limited liability company — — — Balance at June 30, 2015 $ $ $ $ $

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jun. 30, 2016
Share-Based Compensation
Share-Based Compensation	6. Share-Based Compensation During the six months ended June 30, 2016 , activity under the 2007 Stock Option Plan (the “2007 Stock Option Plan”), of UHS Holdco, Inc., our parent company (“Parent”), was as follows: Weighted average Weighted Aggregate remaining Number of average intrinsic contractual (in thousands, except exercise price and years) options exercise price value term (years) Outstanding at December 31, 2015 $ $ Granted Exercised $ Forfeited or expired Outstanding at June 30, 2016 $ $ Exercisable at June 30, 2016 $ $ Remaining authorized options available for issue The exercise price of the stock option award is equal to the market value of Parent’s common stock on the grant date as determined reasonably and in good faith by Parent’s Board of Directors and compensation committee and based on an analysis of a variety of factors, including peer group multiples, merger and acquisition multiples, and discounted cash flow analyses. The intrinsic value of a stock award is the amount by which the market value of the underlying stock exceeds the exercise price of the award. We determine the fair value of stock options using the Black-Scholes option pricing model. The estimated fair value of options, including the effect of estimated forfeitures, is recognized as an expense on a straight-line basis over the options’ expected vesting periods. The following assumptions were used in determining the fair value of stock options granted during the six months ended June 30, 2016 and 2015 under the Black-Scholes model. Six Months Ended June 30, 2016 2015 Risk-free interest rate % % Expected volatility % % Dividend yield N/A N/A Expected option life (years) Black-Scholes Value of options $ $ Expected volatility is based on an independent valuation of the stock of companies within our peer group. Given the lack of a true comparable company, the peer group consists of selected public health care companies representing our suppliers, customers and competitors within certain product lines. The risk free-interest rate is based on the U.S. Treasury yield curve in effect at the grant date based on the expected option life. The expected option life is estimated based on foreseeable trends. At June 30, 2016 , unearned non-cash share-based compensation that we expect to recognize as expense over a weighted average period of 2.2 years totals approximately $6.0 million, net of our estimated forfeiture rate of 2.0% . The expense could be accelerated upon the sale of Parent or the Company. In April 2015, Parent granted the Company’s Chief Executive Officer 7.0 million restricted stock units which vest over four years. Total compensation expense related to this grant was $0.3 million and $0.3 million for the three months ended June 30, 2016 and 2015 , respectively, and $0.6 million and $0.3 million for the six months ended June 30, 2016 and 2015 , respectively . Although Parent grants stock options and restricted stock units, the Company recognizes compensation cost, primarily included in Selling, General and Administrative expense, related to these options and units since the services are performed for its benefit.

Long-Term Debt

Long-Term Debt	6 Months Ended
	Jun. 30, 2016
Long-Term Debt
Long-Term Debt	7. Long-Term Debt Long-term debt consists of the following: June 30, December 31, (in thousands) 2016 2015 Original notes - 7.625% (1) $ $ Add-on notes - 7.625% (2) Senior secured credit facility (3) Capital lease obligations Less: Current portion of long-term debt Total long-term debt $ $ (1) The carrying value of the Original notes - 7.625% is net of unamortized deferred financing costs of $5.1 and $5.7 million as of June 30, 2016 and December 31, 2015 , respectively. (2) The carrying value of the Add-on notes - 7.625% is net of unamortized deferred financing costs of $2.1 and $2.4 million as of June 30, 2016 and December 31, 2015 , respectively, and includes unamortized bond premium of $8.5 and $9.4 million as of June 30, 2016 and December 31, 2015 , respectively. (3) The carrying value of the Senior secured credit facility is net of unamortized deferred financing costs of $2.0 and $2.2 million as of June 30, 2016 and December 31, 2015 , respectively. Original Notes and Add-on Notes — 7.625%. On August 7, 2012, we issued $425.0 million in aggregate principal amount of 7.625 % Second Lien Senior Secured Notes due 2020 (the “Original Notes”) under an indenture dated as of August 7, 2012 (the “2012 Indenture”). On February 12, 2013, we issued $220.0 million in aggregate principal amount of 7.625 % Second Lien Senior Secured Notes due 2020 (the “Add-on Notes”, and along with the Original Notes, the “2012 Notes”) as “additional notes” pursuant to the 2012 Indenture . The 2012 Notes mature on August 15, 2020. The 2012 Indenture provides that the 2012 Notes are our second lien senior secured obligations and are fully and unconditionally guaranteed on a second lien senior secured basis by our existing and certain of our future 100% -owned domestic subsidiaries. Interest on the 2012 Notes is payable entirely in cash, semiannually, in arrears, on February 15 and August 15 of each year, beginning on February 15, 2013. We may redeem some or all of the 2012 Notes at the redemption prices set forth in the 2012 Indenture. If we sell certain assets or undergo certain kinds of changes of control, we must offer to repurchase the 2012 Notes. Our 2012 Notes are subject to certain debt covenants which are described below under the heading “2012 Indenture”. Senior Secured Credit Facility. On November 24, 2015, we entered into a Third Amended and Restated Credit Agreement with Bank of America, N.A., as agent for the lenders, and the lenders party thereto (the “Third Amended Credit Agreement”), which amended our then-existing senior secured credit facility originally dated as of May 31, 2007 and amended and restated as of May 6, 2010 and as of July 31, 2012. We refer to the third amended and restated senior secured credit facility as the “senior secured credit facility.” The senior secured credit facility is a first lien senior secured asset based revolving credit facility that is available for working capital and general corporate purposes, including permitted investments, capital expenditures and debt repayments, on a fully revolving basis, subject to the terms and conditions set forth in the credit documents in the form of revolving loans, swing line loans and letters of credit. The Third Amended Credit Agreement extended the maturity date of the revolving loans to the earliest of (i) November 24, 2020 and (ii) 90 days prior to the maturity of the 2012 Notes, and reduced (a) the interest rate applicable to borrowings under the Third Amended Credit Agreement to a per annum rate, determined based on our usage of the credit facility as provided in the Third Amended Credit Agreement, ranging from 1.50% to 2.00% above the adjusted LIBOR rate used by the agent or, at our option, 0.50% to 1.00% above the Base Rate as defined in the Third Amended Credit Agreement and (b) the unused line fee rate to 0.25% . Our obligations under the Third Amended Credit Agreement are secured by a first priority security interest in substantially all of the assets of the Company, Parent and Surgical Services, excluding a pledge of the Company’s and its subsidiaries’ stock, any joint ventures and certain other exceptions. Our obligations under the Third Amended Credit Agreement are unconditionally guaranteed by the Parent and Surgical Services. Our senior secured credit facility provides the aggregate amount we may borrow under revolving loans up to $235.0 million, subject to our borrowing base. As of June 30, 2016 , we had $131.8 million of availability under the senior secured credit facility based on a borrowing base of $165.5 million less borrowings of $29.2 million and after giving effect to $4.5 million used for letters of credit. The senior secured credit facility requires our compliance with various affirmative and negative covenants. Pursuant to the affirmative covenants, we and Parent agreed to, among other things, deliver financial and other information to the administrative agent, provide notice of certain events (including events of default), pay our obligations, maintain our properties, maintain the security interest in the collateral for the benefit of the administrative agent and the lenders and maintain insurance. Among other restrictions, and subject to certain definitions and exceptions, the senior secured credit facility restricts our ability to: · incur indebtedness; · create or permit liens; · declare or pay dividends and certain other restricted payments; · consolidate, merge or recapitalize; · acquire or sell assets; · make certain investments, loans or other advances; · enter into transactions with affiliates; · change our line of business; and · enter into hedging transactions. The senior secured credit facility also contains a financial covenant that is triggered if our available borrowing capacity is less than $20.0 million for a certain period, which consists of a minimum ratio of trailing four -quarter Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) to cash interest expense, as such terms are defined in the senior secured credit facility. The senior secured credit facility specifies certain events of default, including, among others, failure to pay principal, interest or fees, violation of covenants, inaccuracy of representations or warranties, bankruptcy events, certain ERISA-related events, cross-defaults to other material agreements, change of control events and invalidity of guarantees or security documents. Some events of default will be triggered only after certain cure periods have expired, or will provide for materiality thresholds. If such a default occurs, the lenders under the senior secured credit facility would be entitled to take various actions, including all actions permitted to be taken by a secured creditor and the acceleration of amounts due under the senior secured credit facility. At June 30, 2016 , we had $29.2 million of borrowings outstanding of which $19.0 million was accruing interest at a rate of 2.4471% , $7.0 million was accruing interest at a rate of 2.4461% and $3.2 million was accruing interest at a rate of 4.5% . We were in compliance with all financial debt covenants for all periods presented. 2012 Indenture. Our 2012 Notes are guaranteed, jointly and severally, on a second priority senior secured basis, by Surgical Services, and are also similarly guaranteed by certain of our future 100% -owned domestic subsidiaries. The 2012 Notes are our second priority senior secured obligations and rank (i) equal in right of payment with all of our existing and future unsubordinated indebtedness, and effectively senior to any such unsecured indebtedness to the extent of the value of collateral; (ii) senior in right of payment to all of our and our guarantors’ existing and future subordinated indebtedness; (iii) effectively junior to our senior secured credit facility; and (iv) structurally subordinated to any indebtedness and other liabilities (including trade payables) of any of our future subsidiaries that are not guarantors. The 2012 Indenture governing the 2012 Notes contains covenants that limit our and our guarantors’ ability, subject to certain definitions and exceptions, and certain of our future subsidiaries’ ability to: · incur additional indebtedness; · pay cash dividends or distributions on our capital stock or repurchase our capital stock or subordinated debt; · issue redeemable stock or preferred stock; · issue stock of subsidiaries; · make certain investments; · transfer or sell assets; · create liens on our assets to secure debt; · enter into transactions with affiliates; and · merge or consolidate with another company. The 2012 Indenture specifies certain events of default, including among others, failure to pay principal, interest or premium, violation of covenants and agreements, cross-defaults to other material agreements, bankruptcy events, invalidity of guarantees, and a default in the performance by us of the security documents relating to the 2012 Indenture. Some events of default will be triggered only after certain grace or cure periods have expired, or provide for materiality thresholds. In the event certain bankruptcy-related defaults occur, the 2012 Notes will become due and payable immediately. If any other default occurs, the Trustee (and in some cases the noteholders) would be entitled to take various actions, including acceleration of amounts due under the 2012 Indenture. We were in compliance with all financial debt covenants for all periods presented.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2016
Commitments and Contingencies.
Commitments and Contingencies	8. Commitments and Contingencies The Company, in the ordinary course of business, could be subject to liability claims related to employees and the equipment that it rents and services. Asserted claims are subject to many uncertainties and the outcome of individual matters is not predictable. Certain claims where the loss is probable, a provision is recorded based on the Company’s best estimate. While the ultimate resolution of these actions may have an impact on the Company’s financial results for a particular reporting period, management believes that any such resolution would not have a material adverse effect on the financial position, results of operations or cash flows of the Company and the chance of a negative outcome on outstanding litigation is considered remote. In May 2016, the Company entered into an amendment to an agreement with a supplier. Between the original agreement and this amendment, certain end users described in the original agreement have entered into a direct agreement with the supplier or have elected to participate in a group purchasing organization agreement with the supplier. As a result, the supplier agreed to make a payment of $2.75 million to the Company. The Company recorded a net gain of $2.75 million related to thi s settlement which is reflected as a Gain on settlement in the Consolidated Statements of Operations during the three and six month periods ended June 30, 2016 . On January 13, 2015, the Company filed suit in the Western District of Texas against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc. and Hill-Rom Services, Inc. (the “Defendants”) alleging that the Defendants violated federal and state antitrust laws by willfully and unlawfully engaging in a pattern of exclusionary and predatory conduct in order to foreclose market competition and seeking actual damages, trebled damages and punitive damages. On March 4, 2015, the Defendants filed a motion to transfer the case to another venue. On March 23, 2015, the Defendants filed a motion to dismiss the case. On July 2, 2015, the Court denied the Defendants’ motion to transfer. On October 15, 2015, the Court denied the Defendants motion to dismiss. At this early stage in the litigation, the Company does not believe the expense of litigation will have a material impact on the Company's operating expenses or financial results.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2016
Related Party Transactions
Related Party Transactions	9. Related Party Transactions Management Agreement On May 31, 2007, we and an affiliate of Irving Place Capital (together with its affiliates, “IPC”) entered into a professional services agreement pursuant to which IPC provides general advisory and management services to us with respect to financial and operating matters. IPC is a principal owner of Parent, and the following members of our board of directors are associated with IPC: Robert Juneja and Bret Bowerman. The professional services agreement requires us to pay an annual fee for ongoing advisory and management services equal to the greater of $0.5 million or 0.75% of our Adjusted EBITDA (as defined in the professional services agreement) for the immediately preceding fiscal year, payable in quarterly installments. The professional services agreement provides that IPC will be reimbursed for its reasonable out-of-pocket expenses in connection with certain activities undertaken pursuant to the professional services agreement and will be indemnified for liabilities incurred in connection with its role under the professional services agreement, other than for liabilities resulting from its gross negligence or willful misconduct. The term of the professional services agreement commenced on May 31, 2007 and will remain in effect unless and until either party notifies the other of its desire to terminate, we are sold to a third-party purchaser or we consummate a qualified initial public offering, as defined in the professional services agreement. Total professional services fees incurred to IPC were $0.2 and $0.3 million for the three month periods ended June 30, 2016 and 2015 , respectively, and $0.4 and $0.5 million for the six month periods ended June 30, 2016 and 2015 , respectively . We entered into engagement letters with CTPartners, LLC (“CTPartners”) to conduct searches for certain executive positions. One member o f our board of directors was a former director of CTPartners. Total fees incurred to CTPartners was $0 and $0.2 million for the three month periods ended June 30, 2016 and 2015 , respectively and $0 and $0.2 million during the six month periods ended June 30, 2016 and 2015 , respectively . In connection with the Restricted Stock Unit Award Agreement, dated as of April 13, 2015, between an offcer and the Company, we e ntered into a promissory note agreement with the officer dated April 13, 2016 for a total amount of $1.0 million which is included in other long-term assets in the Consolidated Balance Sheets. This note receivable bears annual interest at 1.45% . The principal and accrued interest of this note is due on the earliest of (i) the seventh anniversary of the date of this loan, (ii) any event with respect to borrower, which, in any such case of the loan were to remain outstanding on and after such date, would result in violation of Section 402 of the Sarbanes-Oxley Act of 2002, (iii) and certain events of default or (iv) a change in control. Interest income for this note was $0.003 and $0.003 million for the three and six month periods ended June 30, 2016.

Limited Liability Companies

Limited Liability Companies	6 Months Ended
	Jun. 30, 2016
Limited Liability Companies.
Limited Liability Companies	10. Limited Liability Companies We participate with others in the formation of LLCs in which Surgical Services becomes a partner and shares the financial interest with the other investors. Surgical Services is the primary beneficiary of these LLCs. These LLCs acquire certain medical equipment for use in their respective business activities, which generally focus on surgical procedures. The LLCs will acquire medical equipment for rental purposes under equipment financing leases. At June 30, 2016 , the LLCs had approximately $0.9 million of total assets. The third party investors in each respective LLC generally provide the lease financing company with individual proportionate lease guarantees based on their respective ownership percentages in the LLCs. In addition, Surgical Services will provide such financing companies with its corporate guarantee based on its respective ownership interest in each LLC. In certain instances, Surgical Services has provided such financing companies with an overall corporate guarantee in connection with equipment financing transactions. In such instances, the individual investors in each respective LLC will generally indemnify us against losses, if any, incurred in connection with its corporate guarantee. Additionally, we provide operational and administrative support to the LLCs in which it is a partner. As of June 30, 2016 , we held interests in s even active LLCs. In accordance with guidance issued by the FASB, we account for equity investments in LLCs (in which we are the primary beneficiary) under the full consolidation method whereby transactions between Surgical Services and the LLCs have been eliminated through consolidation.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2016
Segment Information
Segment Information	11. Segment Information Our reporting segments consist of Medical Equipment Solutions (“MES”), Clinical Engineering Solutions (“CES”) and Surgical Services (“SS”). Certain operating information for our segments as well as a reconciliation of total Company gross margin to loss before income taxes and noncontrolling interest was as follows: Medical Equipment Solutions (in thousands) Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Medical equipment depreciation Gross margin $ $ $ $ Clinical Engineering Solutions (in thousands) Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Gross margin $ $ $ $ Surgical Services (in thousands) Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Medical equipment depreciation Gross margin $ $ $ $ Total Gross Margin and Reconciliation to Loss Before Income Taxes and Noncontrolling Interest (in thousands) Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Total gross margin $ $ $ $ Selling, general and administrative (Gain) on settlement Interest expense Loss before income taxes and noncontrolling interest $ $ $ $ Total Assets by Reporting Segment (in thousands) June 30, December 31, 2016 2015 Medical Equipment Solutions $ $ Clinical Engineering Solutions Surgical Services Total Company Assets $ $ The following table provides additional detail on percentage of revenue for each group of similar products sold or services provided in the MES, CES and SS segments: Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 MES Equipment usage solutions % % % % Equipment/disposable sales CES Service solutions SS Equipment usage solutions Equipment/disposable sales Total revenues % % % %

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2016
Income Taxes
Income Taxes	12. Income Taxes Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. We evaluate the recoverability of our deferred tax assets by scheduling the expected reversals of deferred tax assets and liabilities in order to determine whether net operating loss carry forwards are recoverable prior to expiration and have established a valuation allowance in accordance with ASC Topic 740, “Income Taxes” . The tax expense for the three and six months ended June 30, 2016 primarily relates to state minimum fees. The expected tax benefit from operating loss during the three and six months ended June 30, 2016 was offset by the recording of additional valuation allowance. In future reporting periods, we will continue to assess the likelihood that deferred tax assets will be realizable. At June 30, 2016 , the Company had available unused federal net operating loss carryforwards of approximately $207.1 million. The net operating loss carryforwards will expire at various dates from 2018 through 2036.

Consolidating Financial Stateme

Consolidating Financial Statements	6 Months Ended
	Jun. 30, 2016
Consolidating Financial Statements
Consolidating Financial Statements	13. Consolidating Financial Statements In accordance with the provisions of the 2012 Indenture, as a 100% -owned subsidiary of UHS, Surgical Services has jointly and severally guaranteed all the Company’s Obligations (as defined in the 2012 Indenture) on a full and unconditional basis. Consolidating financial information of UHS and the guarantor is presented on the following pages. Universal Hospital Services, Inc. Consolidating Balance Sheets (in thousands, except share and per share information) (unaudited) June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Assets Current assets: Accounts receivable, less allowance for doubtful accounts $ $ $ — $ Due from affiliates — — Inventories — Other current assets — Total current assets Property and equipment: Medical equipment — Property and office equipment — Accumulated depreciation — Total property and equipment, net — Other long-term assets: Goodwill — Investment in subsidiary — — Other intangibles, net — Other — Total assets $ $ $ $ Liabilities and (Deficit) Equity Current liabilities: Current portion of long-term debt $ $ $ — $ Book overdrafts — Due to affiliates — — Accounts payable — Accrued compensation — Accrued interest — — Other accrued expenses — Total current liabilities Long-term debt, less current portion — Pension and other long-term liabilities — Deferred income taxes, net — Commitments and contingencies (Deficit) Equity Common stock — — — — Additional paid-in capital Accumulated deficit — Accumulated loss in subsidiary — — Accumulated other comprehensive loss — — Total Universal Hospital Services, Inc. (deficit) equity Noncontrolling interest — — Total (deficit) equity Total liabilities and (deficit) equity $ $ $ $ Universal Hospital Services, Inc. Consolidating Balance Sheets (in thousands, except share and per share information) (unaudited) December 31, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Assets Current assets: Accounts receivable, less allowance for doubtful accounts $ $ $ — $ Due from affiliates — — Inventories — Other current assets — Total current assets Property and equipment: Medical equipment — Property and office equipment — Accumulated depreciation — Total property and equipment, net — Other long-term assets: Goodwill — Investment in subsidiary — — Other intangibles, net — Other — Total assets $ $ $ $ Liabilities and (Deficit) Equity Current liabilities: Current portion of long-term debt $ $ $ — $ Book overdrafts — Due to affiliates — — Accounts payable — Accrued compensation — Accrued interest — — Dividend payable — — Other accrued expenses — Total current liabilities Long-term debt, less current portion — Pension and other long-term liabilities — Deferred income taxes, net — Commitments and contingencies (Deficit) Equity Common stock — — — — Additional paid-in capital Accumulated deficit — Accumulated loss in subsidiary — — Accumulated other comprehensive loss — — Total Universal Hospital Services, Inc. (deficit) equity Noncontrolling interest — — Total (deficit) equity Total liabilities and (deficit) equity $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Operations (in thousands) (unaudited) Three Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Operations (in thousands) (unaudited) Three Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Operations (in thousands) (unaudited) Six Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Operations (in thousands) (unaudited) Six Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Comprehensive Income (Loss) (in thousands) (unaudited) Three Months Ended June 30, 2016  Six Months Ended June 30, 2016 Parent Subsidiary Parent Subsidiary Issuer Guarantor Consolidating Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated   UHS Surgical Services Adjustments Consolidated Consolidated net (loss) income $ $ $ $ $ $ $ $ Other comprehensive income: Gain on minimum pension liability, net of tax — — — — Total other comprehensive income — — — — Comprehensive (loss) income Comprehensive income attributable to noncontrolling interest — — — — Comprehensive (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ $ $ $ $ Three Months Ended June 30, 2015  Six Months Ended June 30, 2015 Parent Subsidiary Parent Subsidiary Issuer Guarantor Consolidating Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated UHS Surgical Services Adjustments Consolidated Consolidated net (loss) income $ $ $ $ $ $ $ $ Other comprehensive income: Gain on minimum pension liability, net of tax — — — — Total other comprehensive income — — — — Comprehensive (loss) income Comprehensive income attributable to noncontrolling interest — — — — Comprehensive (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ $ $ $ $ Universal Hospital Services, Inc. Consolidating Statements of Cash Flows (in thousands) (unaudited) Six Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Cash flows from operating activities: Consolidated net (loss) income $ $ $ $ Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation — Amortization of intangibles, deferred financing costs and bond premium — Equity in earnings of subsidiary — — Provision for doubtful accounts — Provision for inventory obsolescence — Non-cash share-based compensation expense — — Gain on sales and disposals of equipment — Deferred income taxes — Interest on note receivable — — Changes in operating assets and liabilities: Accounts receivable — Due from affiliates — — Inventories — Other operating assets — Accounts payable — Other operating liabilities — Net cash provided by operating activities Cash flows from investing activities: Medical equipment purchases — Property and office equipment purchases — Proceeds from disposition of property and equipment — Issuance of note receivable from officer — — Net cash used in investing activities — Cash flows from financing activities: Proceeds under senior secured credit facility — — Payments under senior secured credit facility — — Payments of principal under capital lease obligations — Payments of deferred financing costs — — Holdback payment related to acquisition — — Distributions to noncontrolling interests — — Dividend and equity distribution payments — — Proceeds from exercise of parent company stock options — — Due to affiliates — — Change in book overdrafts — Net cash provided by (used in) financing activities Net change in cash and cash equivalents — — — — Cash and cash equivalents at the beginning of period — — — — Cash and cash equivalents at the end of period $ — $ — $ — $ — Universal Hospital Services, Inc. Consolidating Statements of Cash Flows (in thousands) (unaudited) Six Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Cash flows from operating activities: Consolidated net (loss) income $ $ $ $ Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation — Asset impairment charges — — Amortization of intangibles, deferred financing costs and bond premium — Equity in earnings of subsidiary — — Provision for doubtful accounts — Provision for inventory obsolescence — Non-cash share-based compensation expense — — Gain on sales and disposals of equipment — Deferred income taxes — Changes in operating assets and liabilities: Accounts receivable — Due from affiliates — — Inventories — Other operating assets — Accounts payable — Other operating liabilities — Net cash provided by operating activities Cash flows from investing activities: Medical equipment purchases — Property and office equipment purchases — Proceeds from disposition of property and equipment — Acquisition — — Net cash used in investing activities — Cash flows from financing activities: Proceeds under senior secured credit facility — — Payments under senior secured credit facility — — Payments of principal under capital lease obligations — Distributions to noncontrolling interests — — Contributions from new members to limited liability company — — Dividend and equity distribution payments — — Due to affiliates — — Change in book overdrafts — Net cash (used in) provided by financing activities Net change in cash and cash equivalents — — — — Cash and cash equivalents at the beginning of period — — — — Cash and cash equivalents at the end of period $ — $ — $ — $ —

Restructuring

Restructuring	6 Months Ended
	Jun. 30, 2016
Restructuring
Restructuring	14. Restructuring We incurred no restructuring expense during the three months and six months ended June 30, 2016 and 2015 . As of December 31, 2015 , we had $2.4 million of restructuring liability. For the six months ended June 30, 2016 , $1.9 million in restructuring charges was paid. No additional restructuring was recorded in the first two quarters of 2016 for new severance arrangements and the remaining liability of $0.5 million as of June 30, 2016 is expected to be paid out by the end of the first quarter of 2017 and is included in the “other accrued expenses” in the Consolidated Balance Sheets. As of December 31, 2014, we had $1.6 million of restructuring liability. For the six months ended June 30, 2015 , $1.1 million in restructuring charges was paid. No additional restructuring was recorded in the first two quarters of 2015 for new severance arrangements and the remaining $0.4 million was a liability as of June 30, 2015 .

Concentration

Concentration	6 Months Ended
	Jun. 30, 2016
Concentration
Concentration	15. Concentration One customer accounted for approximately 16% and 14% of total revenue for the six months ended June 30, 2016 and 2015 , respectively.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2016
Fair Value Measurements
Schedule of fair value of assets and liabilities measured on a recurring basis	Fair Value at June 30, 2016 Fair Value at December 31, 2015 (in thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Contingent Consideration $ — $ — $ — $ — $ — $ — $ $
Schedule of reconciliation of the beginning and ending balance for the Level 3 measurement	(in thousands) Balance at December 31, 2015 $ Payments Balance at June 30, 2016 $ —
Schedule of fair value of debt instruments	June 30, 2016 December 31, 2015 Carrying Fair Carrying Fair (in thousands) Value Value Value Value Original notes - 7.625% (1) $ $ $ $ Add-on notes - 7.625% (2) (1) The carrying value of the Original notes - 7.625% is net of unamortized deferred financing costs of $5.1 and $5.7 million as of June 30, 2016 and December 31, 2015 , respectively. (2) The carrying value of the Add-on notes - 7.625% % is net of unamortized deferred financing costs of $2.1 and $2.4 million as of June 30, 2016 and December 31, 2015 , respectively, and includes unamortized bond premium of $8.5 and $9.4 million as of June 30, 2016 and December 31, 2015 , respectively.

Goodwill and Other Intangible24

Goodwill and Other Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2016
Goodwill and Other Intangible Assets
Schedule of goodwill by reporting segment	Medical Clinical Equipment Engineering Surgical (in thousands) Solutions Solutions Services Total Balance at December 31, 2015 $ $ $ $ Acquisition — — — — Balance at June 30, 2016 $ $ $ $
Schedule of other intangible assets	June 30, 2016 December 31, 2015 Accumulated Accumulated (in thousands) Cost Amortization Impairment Net Cost Amortization Impairment Net Finite-life intangibles Customer relationship $ $ $ — $ $ $ $ — $ Supply agreement — — Non-compete agreements — — Total finite-life intangibles — — Indefinite-life intangibles Trade names — — Total intangible assets $ $ $ $ $ $ $ $
Schedule of estimated future amortization expense for identifiable intangible assets	(in thousands) Remainder of 2016 $ 2017 2018 2019 2020 2021

Deficit (Tables)

Deficit (Tables)	6 Months Ended
	Jun. 30, 2016
Deficit
Schedule of changes in equity that are attributable to shareholders and noncontrolling interests	Accumulated Additional Other Paid-in Accumulated Comprehensive Noncontrolling Total (in thousands) Capital Deficit Loss Interests Deficit Balance at December 31, 2015 $ $ $ $ $ Net (loss) income — — Other comprehensive income — — — Share-based compensation — — — Stock option exercised — — — Cash distributions to noncontrolling interests — — — Balance at June 30, 2016 $ $ $ $ $ Accumulated Additional Other Paid-in Accumulated Comprehensive Noncontrolling Total (in thousands) Capital Deficit Loss Interests Deficit Balance at December 31, 2014 $ $ $ $ $ Net (loss) income — — Other comprehensive income — — — Cash distributions to noncontrolling interests — — — Contributions from new members to limited liability company — — — Balance at June 30, 2015 $ $ $ $ $

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2016
Share-Based Compensation
Schedule of activity of parent company under the 2007 Stock Option Plan	Weighted average Weighted Aggregate remaining Number of average intrinsic contractual (in thousands, except exercise price and years) options exercise price value term (years) Outstanding at December 31, 2015 $ $ Granted Exercised $ Forfeited or expired Outstanding at June 30, 2016 $ $ Exercisable at June 30, 2016 $ $ Remaining authorized options available for issue
Schedule of assumptions used in determining the fair value of stock options granted under the Black-Scholes model	Six Months Ended June 30, 2016 2015 Risk-free interest rate % % Expected volatility % % Dividend yield N/A N/A Expected option life (years) Black-Scholes Value of options $ $

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Jun. 30, 2016
Long-Term Debt
Schedule of long-term debt	June 30, December 31, (in thousands) 2016 2015 Original notes - 7.625% (1) $ $ Add-on notes - 7.625% (2) Senior secured credit facility (3) Capital lease obligations Less: Current portion of long-term debt Total long-term debt $ $ (1) The carrying value of the Original notes - 7.625% is net of unamortized deferred financing costs of $5.1 and $5.7 million as of June 30, 2016 and December 31, 2015 , respectively. (2) The carrying value of the Add-on notes - 7.625% is net of unamortized deferred financing costs of $2.1 and $2.4 million as of June 30, 2016 and December 31, 2015 , respectively, and includes unamortized bond premium of $8.5 and $9.4 million as of June 30, 2016 and December 31, 2015 , respectively. The carrying value of the Senior secured credit facility is net of unamortized deferred financing costs of $2.0 and $2.2 million as of June 30, 2016 and December 31, 2015 , respectively.

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2016
Segment Information
Schedule of the total gross margin and reconciliation to loss before income taxes and noncontrolling interest (in thousands)	Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Total gross margin $ $ $ $ Selling, general and administrative (Gain) on settlement Interest expense Loss before income taxes and noncontrolling interest $ $ $ $
Schedule of total assets by reporting segment (in thousands)	June 30, December 31, 2016 2015 Medical Equipment Solutions $ $ Clinical Engineering Solutions Surgical Services Total Company Assets $ $
Schedule of percentage of revenue for each group of similar products sold or services provided in segments	Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 MES Equipment usage solutions % % % % Equipment/disposable sales CES Service solutions SS Equipment usage solutions Equipment/disposable sales Total revenues % % % %
Medical Equipment Solutions
Segment Information
Schedule of operating information of segments (in thousands)	Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Medical equipment depreciation Gross margin $ $ $ $
Clinical Engineering Solutions
Segment Information
Schedule of operating information of segments (in thousands)	Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Gross margin $ $ $ $
Surgical Services
Segment Information
Schedule of operating information of segments (in thousands)	Three Months Ended Six Months Ended June 30, June 30, 2016 2015 2016 2015 Revenues $ $ $ $ Cost of revenue Medical equipment depreciation Gross margin $ $ $ $

Consolidating Financial State29

Consolidating Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2016
Consolidating Financial Statements
Schedule of Consolidating Balance Sheets	June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Assets Current assets: Accounts receivable, less allowance for doubtful accounts $ $ $ — $ Due from affiliates — — Inventories — Other current assets — Total current assets Property and equipment: Medical equipment — Property and office equipment — Accumulated depreciation — Total property and equipment, net — Other long-term assets: Goodwill — Investment in subsidiary — — Other intangibles, net — Other — Total assets $ $ $ $ Liabilities and (Deficit) Equity Current liabilities: Current portion of long-term debt $ $ $ — $ Book overdrafts — Due to affiliates — — Accounts payable — Accrued compensation — Accrued interest — — Other accrued expenses — Total current liabilities Long-term debt, less current portion — Pension and other long-term liabilities — Deferred income taxes, net — Commitments and contingencies (Deficit) Equity Common stock — — — — Additional paid-in capital Accumulated deficit — Accumulated loss in subsidiary — — Accumulated other comprehensive loss — — Total Universal Hospital Services, Inc. (deficit) equity Noncontrolling interest — — Total (deficit) equity Total liabilities and (deficit) equity $ $ $ $ December 31, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Assets Current assets: Accounts receivable, less allowance for doubtful accounts $ $ $ — $ Due from affiliates — — Inventories — Other current assets — Total current assets Property and equipment: Medical equipment — Property and office equipment — Accumulated depreciation — Total property and equipment, net — Other long-term assets: Goodwill — Investment in subsidiary — — Other intangibles, net — Other — Total assets $ $ $ $ Liabilities and (Deficit) Equity Current liabilities: Current portion of long-term debt $ $ $ — $ Book overdrafts — Due to affiliates — — Accounts payable — Accrued compensation — Accrued interest — — Dividend payable — — Other accrued expenses — Total current liabilities Long-term debt, less current portion — Pension and other long-term liabilities — Deferred income taxes, net — Commitments and contingencies (Deficit) Equity Common stock — — — — Additional paid-in capital Accumulated deficit — Accumulated loss in subsidiary — — Accumulated other comprehensive loss — — Total Universal Hospital Services, Inc. (deficit) equity Noncontrolling interest — — Total (deficit) equity Total liabilities and (deficit) equity $ $ $ $
Schedule of Consolidating Statements of Operations	Three Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Three Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Six Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ Six Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Revenue Medical equipment solutions $ $ — $ — $ Clinical engineering solutions — — Surgical services — — Total revenues — Cost of Revenue Cost of medical equipment solutions — — Cost of clinical engineering solutions — — Cost of surgical services — — Medical equipment depreciation — Total costs of revenues — Gross margin — Selling, general and administrative — (Gain) on settlement — — Operating income — Equity in earnings of subsidiary — — Interest expense — (Loss) income before income taxes and noncontrolling interest (Benefit) provision for income taxes — Consolidated net (loss) income Net income attributable to noncontrolling interest — — Net (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $
Schedule of Consolidating Statements of Comprehensive Income (Loss)	Three Months Ended June 30, 2016  Six Months Ended June 30, 2016 Parent Subsidiary Parent Subsidiary Issuer Guarantor Consolidating Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated   UHS Surgical Services Adjustments Consolidated Consolidated net (loss) income $ $ $ $ $ $ $ $ Other comprehensive income: Gain on minimum pension liability, net of tax — — — — Total other comprehensive income — — — — Comprehensive (loss) income Comprehensive income attributable to noncontrolling interest — — — — Comprehensive (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ $ $ $ $ Three Months Ended June 30, 2015  Six Months Ended June 30, 2015 Parent Subsidiary Parent Subsidiary Issuer Guarantor Consolidating Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated UHS Surgical Services Adjustments Consolidated Consolidated net (loss) income $ $ $ $ $ $ $ $ Other comprehensive income: Gain on minimum pension liability, net of tax — — — — Total other comprehensive income — — — — Comprehensive (loss) income Comprehensive income attributable to noncontrolling interest — — — — Comprehensive (loss) income attributable to Universal Hospital Services, Inc. $ $ $ $ $ $ $ $
Schedule of Consolidating Statements of Cash Flows	Six Months Ended June 30, 2016 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Cash flows from operating activities: Consolidated net (loss) income $ $ $ $ Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation — Amortization of intangibles, deferred financing costs and bond premium — Equity in earnings of subsidiary — — Provision for doubtful accounts — Provision for inventory obsolescence — Non-cash share-based compensation expense — — Gain on sales and disposals of equipment — Deferred income taxes — Interest on note receivable — — Changes in operating assets and liabilities: Accounts receivable — Due from affiliates — — Inventories — Other operating assets — Accounts payable — Other operating liabilities — Net cash provided by operating activities Cash flows from investing activities: Medical equipment purchases — Property and office equipment purchases — Proceeds from disposition of property and equipment — Issuance of note receivable from officer — — Net cash used in investing activities — Cash flows from financing activities: Proceeds under senior secured credit facility — — Payments under senior secured credit facility — — Payments of principal under capital lease obligations — Payments of deferred financing costs — — Holdback payment related to acquisition — — Distributions to noncontrolling interests — — Dividend and equity distribution payments — — Proceeds from exercise of parent company stock options — — Due to affiliates — — Change in book overdrafts — Net cash provided by (used in) financing activities Net change in cash and cash equivalents — — — — Cash and cash equivalents at the beginning of period — — — — Cash and cash equivalents at the end of period $ — $ — $ — $ — Six Months Ended June 30, 2015 Parent Subsidiary Issuer Guarantor Consolidating UHS Surgical Services Adjustments Consolidated Cash flows from operating activities: Consolidated net (loss) income $ $ $ $ Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation — Asset impairment charges — — Amortization of intangibles, deferred financing costs and bond premium — Equity in earnings of subsidiary — — Provision for doubtful accounts — Provision for inventory obsolescence — Non-cash share-based compensation expense — — Gain on sales and disposals of equipment — Deferred income taxes — Changes in operating assets and liabilities: Accounts receivable — Due from affiliates — — Inventories — Other operating assets — Accounts payable — Other operating liabilities — Net cash provided by operating activities Cash flows from investing activities: Medical equipment purchases — Property and office equipment purchases — Proceeds from disposition of property and equipment — Acquisition — — Net cash used in investing activities — Cash flows from financing activities: Proceeds under senior secured credit facility — — Payments under senior secured credit facility — — Payments of principal under capital lease obligations — Distributions to noncontrolling interests — — Contributions from new members to limited liability company — — Dividend and equity distribution payments — — Due to affiliates — — Change in book overdrafts — Net cash (used in) provided by financing activities Net change in cash and cash equivalents — — — — Cash and cash equivalents at the beginning of period — — — — Cash and cash equivalents at the end of period $ — $ — $ — $ —

Basis of Presentation (Details)

Basis of Presentation (Details)	Jun. 30, 2016
Basis of Presentation
Ownership interest in subsidiary (as a percent)	100.00%

Recent Accounting Pronounceme31

Recent Accounting Pronouncements (Details) - USD ($) $ in Thousands	Jul. 09, 2015	Jun. 30, 2016	Dec. 31, 2015
New Accounting Pronouncements or Change in Accounting Principle
Long-term debt, less current portion		$ 684,173	$ 682,591
Other		$ 1,668	420
Accounting Standards Update 2015 3
New Accounting Pronouncements or Change in Accounting Principle
Long-term debt, less current portion			(10,300)
Other			$ (10,300)
Accounting Standards Update 2014 9
New Accounting Pronouncements or Change in Accounting Principle
Accounting Standards Update Deferral Period	1 year

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Fair value measurements
Earn-out payments paid	$ 0	$ 10	$ 500	$ 20
Recurring basis
Fair value measurements
Contingent Consideration					$ 502
Recurring basis | Level 3
Fair value measurements
Contingent Consideration					$ 502
Reconciliation of the beginning and ending balance for the Level 3 measurement
Balance at the beginning of the period			502
Payments			$ (502)

Fair Value Measurements - Other

Fair Value Measurements - Other Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Feb. 12, 2013	Aug. 07, 2012
Original notes - 7.625%
Fair Value of Other Financial Instruments
Carrying Value	$ 419,898	$ 419,274
Fair Value	$ 392,062	$ 401,094
Interest rate (as a percent)	7.625%	7.625%		7.625%
Unamortized deferred financing costs	$ 5,100	$ 5,700
Add-on notes - 7.625%
Fair Value of Other Financial Instruments
Carrying Value	226,401	227,029
Fair Value	$ 202,950	$ 207,625
Interest rate (as a percent)	7.625%	7.625%	7.625%
Unamortized deferred financing costs	$ 2,100	$ 2,400
Unamortized bond premium	$ 8,500	$ 9,400

Goodwill and Other Intangible34

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Goodwill
Balance at the beginning of the period			$ 336,595
Balance at the end of the period	$ 336,595		336,595
Other intangible assets
Cost	143,987		143,987		$ 143,987
Accumulated Amortization	(118,486)		(118,486)		(112,733)
Total	25,501		25,501		31,254
Accumulated Impairment	(34,900)		(34,900)		(34,900)
Cost	309,987		309,987		309,987
Net	156,601		156,601		162,354
Total amortization expense	2,800	$ 3,000	5,800	$ 6,100
Trade names
Other intangible assets
Cost	166,000		166,000		166,000
Accumulated Impairment	(34,900)		(34,900)		(34,900)
Net	131,100		131,100		131,100
Customer relationship
Other intangible assets
Cost	117,039		117,039		117,039
Accumulated Amortization	(93,887)		(93,887)		(89,663)
Total	23,152		23,152		27,376
Supply agreement
Other intangible assets
Cost	26,000		26,000		26,000
Accumulated Amortization	(23,822)		(23,822)		(22,369)
Total	2,178		2,178		3,631
Non-compete agreements
Other intangible assets
Cost	948		948		948
Accumulated Amortization	(777)		(777)		(701)
Total	171		171		$ 247
Medical Equipment Solutions
Goodwill
Balance at the beginning of the period			227,486
Balance at the end of the period	227,486		227,486
Clinical Engineering Solutions
Goodwill
Balance at the beginning of the period			55,655
Acquisitions
Balance at the end of the period	55,655		55,655
Surgical Services
Goodwill
Balance at the beginning of the period			53,454
Balance at the end of the period	$ 53,454		$ 53,454

Goodwill and Other Intangible35

Goodwill and Other Intangible Assets - Amortization (Details) $ in Thousands	Jun. 30, 2016USD ($)
Future estimated amortization expense
Remainder of 2016	$ 5,219
2,017	7,679
2,018	6,095
2,019	3,529
2,020	1,537
2,021	$ 877

Deficit (Details)

Deficit (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Changes in shareholders equity that are attributable to shareholders and noncontrolling interests
Balance			$ (49,158)	$ (48,747)
Net (loss) income	$ (609)	$ (1,779)	(5,249)	(8,745)
Other comprehensive income (loss)	184	488	370	488
Share-based compensation			1,514
Stock option exercised			66
Cash distributions to noncontrolling interests			(196)	(240)
Contributions from new members to limited liability companies				70
Balance	(52,653)	(57,174)	(52,653)	(57,174)
Additional Paid-in Capital
Changes in shareholders equity that are attributable to shareholders and noncontrolling interests
Balance			241,833	214,514
Net (loss) income
Share-based compensation			1,514
Stock option exercised			66
Balance	243,413	214,514	243,413	214,514
Accumulated Deficit
Changes in shareholders equity that are attributable to shareholders and noncontrolling interests
Balance			(283,066)	(254,418)
Net (loss) income			(5,384)	(8,965)
Balance	(288,450)	(263,383)	(288,450)	(263,383)
Accumulated Other Comprehensive Loss
Changes in shareholders equity that are attributable to shareholders and noncontrolling interests
Balance			(8,165)	(9,062)
Net (loss) income
Other comprehensive income (loss)			370	488
Balance	(7,795)	(8,574)	(7,795)	(8,574)
Noncontrolling Interests
Changes in shareholders equity that are attributable to shareholders and noncontrolling interests
Balance			240	219
Net (loss) income			135	220
Cash distributions to noncontrolling interests			(196)	(240)
Contributions from new members to limited liability companies				70
Balance	$ 179	$ 269	$ 179	$ 269

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended	12 Months Ended
	Apr. 30, 2015	Jun. 30, 2016	Dec. 31, 2015
Restricted Stock Units (RSUs)
Number of Options
Granted (in shares)	7,000,000
Parent Issuer UHS | Options
Number of Options
Outstanding at the beginning of the period (in shares)		33,889,000
Granted (in shares)		5,773,000
Exercised (in shares)		(93,000)
Forfeited or expired (in shares)		(3,140,000)
Outstanding at the end of the period (in shares)		36,429,000	33,889,000
Exercisable at the end of the period (in shares)		12,293,000
Remaining authorized options available for issue		7,163,000
Weighted average exercise price
Outstanding at the beginning of the period (in dollars per share)		$ 0.71
Granted (in dollars per share)		1.02
Exercised (in dollars per share)		0.71
Forfeited or expired (in dollars per share)		0.71
Outstanding at the end of the period (in dollars per share)		0.76	$ 0.71
Exercisable at the end of the period (in dollars per share)		$ 0.71
Aggregate intrinsic value
Outstanding		$ 9,519	$ 10,506
Exercisable		3,811
Exercised		$ 29
Weighted average remaining contractual term
Outstanding		8 years 4 months 24 days	8 years 10 months 24 days
Exercisable		8 years 4 months 24 days

Share-Based Compensation - Assu

Share-Based Compensation - Assumption (Details) - Parent Issuer UHS - Options - $ / shares	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Assumptions used in determining the fair value of stock options granted under the Black-Scholes model
Risk-free interest rate (as a percent)	1.50%	1.70%
Expected volatility (as a percent)	30.90%	26.90%
Expected option life	5 years 9 months 29 days	5 years 1 month 6 days
Black-Scholes Value of options (in dollars per share)	$ 0.33	$ 0.19

Share-Based Compensation - Unea

Share-Based Compensation - Unearned Non-cash shared-based compensation (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Apr. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Stock-based compensation
Share-based Compensation.				$ 1,514	$ 1,140
Unearned non-cash share-based compensation
Weighted average period for recognition of share-based compensation expense				2 years 2 months 12 days
Unearned non-cash share-based compensation expense expected to be recognized		$ 6,000		$ 6,000
Estimated forfeiture rate (as a percent)				2.00%
Compensation expense		$ 300	$ 300	$ 600	$ 300
Restricted Stock Units (RSUs)
Unearned non-cash share-based compensation
Granted (in shares)	7,000,000
Vesting period	4 years

Long-Term Debt (Details)

Long-Term Debt (Details)	6 Months Ended
	Jun. 30, 2016USD ($)item	Dec. 31, 2015USD ($)	Feb. 12, 2013USD ($)	Aug. 07, 2012USD ($)
Long-Term Debt
Long-term debt current and noncurrent	$ 689,358,000	$ 687,458,000
Less: Current portion of long-term debt	(5,185,000)	(4,867,000)
Total long-term debt	$ 684,173,000	682,591,000
Ownership interest in existing and certain future owned domestic subsidiaries (as a percent)	100.00%
Original notes - 7.625%
Long-Term Debt
Long-term debt current and noncurrent	$ 419,898,000	$ 419,274,000
Interest rate (as a percent)	7.625%	7.625%		7.625%
Unamortized deferred financing costs	$ 5,100,000	$ 5,700,000
Aggregate outstanding principal amount				$ 425,000,000
Add-on notes - 7.625%
Long-Term Debt
Long-term debt current and noncurrent	226,401,000	227,029,000
Unamortized bond premium	$ 8,500,000	$ 9,400,000
Interest rate (as a percent)	7.625%	7.625%	7.625%
Unamortized deferred financing costs	$ 2,100,000	$ 2,400,000
Aggregate outstanding principal amount			$ 220,000,000
Senior secured credit facility
Long-Term Debt
Long-term debt current and noncurrent	27,176,000	25,811,000
Unamortized deferred financing costs	2,000,000	2,200,000
Maximum borrowing capacity	235,000,000
Available amount	131,800,000
Borrowing base	165,500,000
Borrowing outstanding	29,200,000
Letters of credit	4,500,000
Minimum available borrowing capacity required to be maintained for a certain period under financial covenants	$ 20,000,000
Minimum ratio of EBITDA to cash expense, number of quarters | item	4
Senior secured credit facility | Interest Rate Scenario 1
Long-Term Debt
Borrowing outstanding	$ 19,000,000
Debt Instrument, Interest Rate at Period End	2.4471%
Senior secured credit facility | Interest Rate Scenario 2
Long-Term Debt
Borrowing outstanding	$ 7,000,000
Debt Instrument, Interest Rate at Period End	2.4461%
Senior secured credit facility | Interest Rate Scenario 3
Long-Term Debt
Borrowing outstanding	$ 3,200,000
Debt Instrument, Interest Rate at Period End	4.50%
Capital lease obligations
Long-Term Debt
Long-term debt current and noncurrent	$ 15,883,000	$ 15,344,000
Third Amended and Restated Credit Agreement
Long-Term Debt
Unused Capacity, Commitment Fee Percentage	0.25%
Period prior to maturity	90 days
Third Amended and Restated Credit Agreement | Base Rate | Minimum
Long-Term Debt
Margin over base rate (as a percent)	0.50%
Third Amended and Restated Credit Agreement | Base Rate | Maximum
Long-Term Debt
Margin over base rate (as a percent)	1.00%
Third Amended and Restated Credit Agreement | Adjusted LIBOR | Minimum
Long-Term Debt
Margin over base rate (as a percent)	1.50%
Third Amended and Restated Credit Agreement | Adjusted LIBOR | Maximum
Long-Term Debt
Margin over base rate (as a percent)	2.00%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Commitments and Contingencies.
Gain on settlement	$ 2,750	$ 5,718	$ 2,750	$ 5,718

Related Party Transactions (Det

Related Party Transactions (Details) $ in Thousands	Apr. 13, 2016USD ($)	Jun. 30, 2016USD ($)item	Jun. 30, 2015USD ($)	Jun. 30, 2016USD ($)item	Jun. 30, 2015USD ($)
Related Party Transaction
Interest income				$ 3
IPC | General Advisory And Management Services
Related Party Transaction
Specified amount of annual fees for ongoing advisory and management services				$ 500
Annual fee for ongoing advisory and management services as a percentage of adjusted EBITDA				0.75%
Amount incurred		$ 200	$ 300	$ 400	$ 500
CT Partners | Executive Positions Search Services
Related Party Transaction
Number of members of the board of directors involved in the related party transaction | item		1		1
Amount incurred		$ 0	$ 200	$ 0	$ 200
Officer | Promissory Note Agreement
Related Party Transaction
Interest rate	1.45%
Interest income		$ 3		$ 3
Officer | Promissory Note Agreement | Other Noncurrent Assets
Related Party Transaction
Note receivable	$ 1,000

Limited Liability Companies (De

Limited Liability Companies (Details) - Limited Liability Companies $ in Millions	Jun. 30, 2016USD ($)item
Limited Liability Companies
Number of active LLCs in which the entity holds an interest | item	7
Surgical Services
Limited Liability Companies
Total assets of LLCs | $	$ 0.9

Segment Information - Reportabl

Segment Information - Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Segment Information
Revenues	$ 117,618	$ 112,289	$ 239,744	$ 225,775
Medical equipment depreciation	16,077	15,501	31,247	33,635
Gross margin	38,728	36,972	78,613	73,636
Selling, general and administrative	28,798	31,038	60,095	61,189
(Gain) on settlement	(2,750)	(5,718)	(2,750)	(5,718)
Interest expense	13,061	13,249	26,130	26,559
Loss before income taxes and noncontrolling interest	(381)	(1,597)	(4,862)	(8,394)
Assets	786,310		786,310		$ 797,575
Medical Equipment Solutions
Segment Information
Revenues	74,940	71,084	155,170	145,169
Cost of revenue	33,213	31,053	71,494	62,331
Medical equipment depreciation	14,628	14,009	28,381	30,669
Gross margin	27,099	26,022	55,295	52,169
Assets	575,833		575,833		585,990
Clinical Engineering Solutions
Segment Information
Revenues	25,464	24,784	51,042	49,179
Cost of revenue	20,644	20,041	40,668	39,271
Gross margin	4,820	4,743	10,374	9,908
Assets	111,150		111,150		110,588
Surgical Services
Segment Information
Revenues	17,214	16,421	33,532	31,427
Cost of revenue	8,956	8,722	17,722	16,902
Medical equipment depreciation	1,449	1,492	2,866	2,966
Gross margin	6,809	$ 6,207	12,944	$ 11,559
Assets	$ 99,327		$ 99,327		$ 100,997

Segment Information - Concentra

Segment Information - Concentration (Details) - Revenue - Product concentration risk	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
Medical Equipment Solutions
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	63.70%	63.30%	64.70%	64.30%
Medical Equipment Solutions | Equipment usage solutions
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	61.10%	60.10%	60.40%	61.20%
Medical Equipment Solutions | Equipment/disposable sales
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	2.60%	3.20%	4.30%	3.10%
Clinical Engineering Solutions | Service solutions
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	21.60%	22.10%	21.30%	21.80%
Surgical Services
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	14.70%	14.60%	14.00%	13.90%
Surgical Services | Equipment usage solutions
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	14.50%	14.40%	13.80%	13.70%
Surgical Services | Equipment/disposable sales
Details on the percentage of revenue for each group of similar products sold or services provided in segments
Percentage of revenue	0.20%	0.20%	0.20%	0.20%

Income Taxes (Details)

Income Taxes (Details) $ in Millions	Jun. 30, 2016USD ($)
Federal
Operating loss carryforwards
Unused federal net operating loss carryforwards	$ 207.1

Consolidating Financial State47

Consolidating Financial Statements (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
Consolidating Financial Statements
Ownership interest in subsidiary (as a percent)	100.00%
Current assets:
Accounts receivable, less allowance for doubtful accounts	$ 76,423	$ 71,252
Inventories	8,500	8,506
Other current assets	6,672	5,834
Total current assets	91,595	85,592
Property and equipment:
Medical equipment	595,635	590,091
Property and office equipment	88,872	85,341
Accumulated depreciation	(484,656)	(462,818)
Total property and equipment, net	199,851	212,614
Other long-term assets:
Goodwill	336,595	336,595
Other intangibles, net	156,601	162,354
Other	1,668	420
Total assets	786,310	797,575
Current liabilities:
Current portion of long-term debt	5,185	4,867
Book overdrafts	9,469	6,444
Accounts payable	25,689	31,073
Accrued compensation	15,109	23,600
Accrued interest	18,650	18,742
Dividend payable		24
Other accrued expenses	15,988	14,564
Total current liabilities	90,090	99,314
Long-term debt, less current portion	684,173	682,591
Pension and other long-term liabilities	11,621	11,869
Deferred income taxes, net	53,079	52,959
Commitments and contingencies
(Deficit) Equity
Common stock
Additional paid-in capital	243,413	241,833
Accumulated deficit	(288,450)	(283,066)
Accumulated other comprehensive loss	(7,795)	(8,165)
Total Universal Hospital Services, Inc. deficit	(52,832)	(49,398)
Noncontrolling interest	179	240
Total deficit	(52,653)	(49,158)	$ (57,174)	$ (48,747)
Total liabilities and deficit	786,310	797,575
Consolidating Adjustments
Current assets:
Due from affiliates	(30,525)	(29,145)
Total current assets	(30,525)	(29,145)
Other long-term assets:
Investment in subsidiary	(55,516)	(54,383)
Total assets	(86,041)	(83,528)
Current liabilities:
Due to affiliates	(30,525)	(29,145)
Total current liabilities	(30,525)	(29,145)
(Deficit) Equity
Additional paid-in capital	(60,019)	(60,019)
Accumulated loss in subsidiary	4,503	5,636
Total Universal Hospital Services, Inc. deficit	(55,516)	(54,383)
Total deficit	(55,516)	(54,383)
Total liabilities and deficit	(86,041)	(83,528)
Parent Issuer UHS
Current assets:
Accounts receivable, less allowance for doubtful accounts	67,326	62,288
Due from affiliates	30,525	29,145
Inventories	5,266	4,533
Other current assets	6,453	5,670
Total current assets	109,570	101,636
Property and equipment:
Medical equipment	544,124	541,200
Property and office equipment	79,155	76,436
Accumulated depreciation	(444,245)	(425,574)
Total property and equipment, net	179,034	192,062
Other long-term assets:
Goodwill	283,141	283,141
Investment in subsidiary	55,516	54,383
Other intangibles, net	144,474	148,520
Other	1,289	364
Total assets	773,024	780,106
Current liabilities:
Current portion of long-term debt	3,965	3,801
Book overdrafts	9,227	5,875
Accounts payable	22,584	25,260
Accrued compensation	13,097	21,266
Accrued interest	18,650	18,742
Dividend payable		24
Other accrued expenses	15,789	13,913
Total current liabilities	83,312	88,881
Long-term debt, less current portion	680,682	679,321
Pension and other long-term liabilities	11,611	11,850
Deferred income taxes, net	50,236	49,437
(Deficit) Equity
Additional paid-in capital	243,428	241,848
Accumulated deficit	(283,947)	(277,430)
Accumulated loss in subsidiary	(4,503)	(5,636)
Accumulated other comprehensive loss	(7,795)	(8,165)
Total Universal Hospital Services, Inc. deficit	(52,817)	(49,383)
Total deficit	(52,817)	(49,383)
Total liabilities and deficit	773,024	780,106
Subsidiary Guarantor Surgical Services
Current assets:
Accounts receivable, less allowance for doubtful accounts	9,097	8,964
Inventories	3,234	3,973
Other current assets	219	164
Total current assets	12,550	13,101
Property and equipment:
Medical equipment	51,511	48,891
Property and office equipment	9,717	8,905
Accumulated depreciation	(40,411)	(37,244)
Total property and equipment, net	20,817	20,552
Other long-term assets:
Goodwill	53,454	53,454
Other intangibles, net	12,127	13,834
Other	379	56
Total assets	99,327	100,997
Current liabilities:
Current portion of long-term debt	1,220	1,066
Book overdrafts	242	569
Due to affiliates	30,525	29,145
Accounts payable	3,105	5,813
Accrued compensation	2,012	2,334
Other accrued expenses	199	651
Total current liabilities	37,303	39,578
Long-term debt, less current portion	3,491	3,270
Pension and other long-term liabilities	10	19
Deferred income taxes, net	2,843	3,522
(Deficit) Equity
Additional paid-in capital	60,004	60,004
Accumulated deficit	(4,503)	(5,636)
Total Universal Hospital Services, Inc. deficit	55,501	54,368
Noncontrolling interest	179	240
Total deficit	55,680	54,608
Total liabilities and deficit	$ 99,327	$ 100,997

Consolidating Financial State48

Consolidating Financial Statements - Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenue
Medical equipment solutions	$ 74,940	$ 71,084	$ 155,170	$ 145,169
Clinical engineering solutions	25,464	24,784	51,042	49,179
Surgical services	17,214	16,421	33,532	31,427
Total revenues	117,618	112,289	239,744	225,775
Cost of Revenue
Cost of medical equipment solutions	33,213	31,053	71,494	62,331
Cost of clinical engineering solutions	20,644	20,041	40,668	39,271
Cost of surgical services	8,956	8,722	17,722	16,902
Medical equipment depreciation	16,077	15,501	31,247	33,635
Total costs of revenues	78,890	75,317	161,131	152,139
Gross margin	38,728	36,972	78,613	73,636
Selling, general and administrative	28,798	31,038	60,095	61,189
(Gain) on settlement	(2,750)	(5,718)	(2,750)	(5,718)
Operating income	12,680	11,652	21,268	18,165
Interest expense	13,061	13,249	26,130	26,559
Loss before income taxes and noncontrolling interest	(381)	(1,597)	(4,862)	(8,394)
Provision (benefit) for income taxes	228	182	387	351
Consolidated net loss	(609)	(1,779)	(5,249)	(8,745)
Net income attributable to noncontrolling interest	75	95	135	220
Net loss attributable to Universal Hospital Services, Inc.	(684)	(1,874)	(5,384)	(8,965)
Consolidating Adjustments
Cost of Revenue
Equity in earnings of subsidiary	901	573	1,268	759
Loss before income taxes and noncontrolling interest	(901)	(573)	(1,268)	(759)
Consolidated net loss	(901)	(573)	(1,268)	(759)
Net loss attributable to Universal Hospital Services, Inc.	(901)	(573)	(1,268)	(759)
Parent Issuer UHS
Revenue
Medical equipment solutions	74,940	71,084	155,170	145,169
Clinical engineering solutions	25,464	24,784	51,042	49,179
Total revenues	100,404	95,868	206,212	194,348
Cost of Revenue
Cost of medical equipment solutions	33,213	31,053	71,494	62,331
Cost of clinical engineering solutions	20,644	20,041	40,668	39,271
Medical equipment depreciation	14,628	14,009	28,381	30,669
Total costs of revenues	68,485	65,103	140,543	132,271
Gross margin	31,919	30,765	65,669	62,077
Selling, general and administrative	24,123	26,436	50,459	52,018
(Gain) on settlement	(2,750)	(5,718)	(2,750)	(5,718)
Operating income	10,546	10,047	17,960	15,777
Equity in earnings of subsidiary	(901)	(573)	(1,268)	(759)
Interest expense	12,528	12,734	25,053	25,525
Loss before income taxes and noncontrolling interest	(1,081)	(2,114)	(5,825)	(8,989)
Provision (benefit) for income taxes	(472)	(335)	(576)	(244)
Consolidated net loss	(609)	(1,779)	(5,249)	(8,745)
Net loss attributable to Universal Hospital Services, Inc.	(609)	(1,779)	(5,249)	(8,745)
Subsidiary Guarantor Surgical Services
Revenue
Surgical services	17,214	16,421	33,532	31,427
Total revenues	17,214	16,421	33,532	31,427
Cost of Revenue
Cost of surgical services	8,956	8,722	17,722	16,902
Medical equipment depreciation	1,449	1,492	2,866	2,966
Total costs of revenues	10,405	10,214	20,588	19,868
Gross margin	6,809	6,207	12,944	11,559
Selling, general and administrative	4,675	4,602	9,636	9,171
Operating income	2,134	1,605	3,308	2,388
Interest expense	533	515	1,077	1,034
Loss before income taxes and noncontrolling interest	1,601	1,090	2,231	1,354
Provision (benefit) for income taxes	700	517	963	595
Consolidated net loss	901	573	1,268	759
Net income attributable to noncontrolling interest	75	95	135	220
Net loss attributable to Universal Hospital Services, Inc.	$ 826	$ 478	$ 1,133	$ 539

Consolidating Financial State49

Consolidating Financial Statements - Comp Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Consolidating Financial Statements
Consolidated net (loss) income	$ (609)	$ (1,779)	$ (5,249)	$ (8,745)
Other comprehensive income:
Gain on minimum pension liability, net of tax	184	488	370	488
Total other comprehensive income	184	488	370	488
Comprehensive (loss) income	(425)	(1,291)	(4,879)	(8,257)
Comprehensive income attributable to noncontrolling interest	75	95	135	220
Comprehensive (loss) income attributable to Universal Hospital Services, Inc.	(500)	(1,386)	(5,014)	(8,477)
Consolidating Adjustments
Consolidating Financial Statements
Consolidated net (loss) income	(901)	(573)	(1,268)	(759)
Other comprehensive income:
Comprehensive (loss) income	(901)	(573)	(1,268)	(759)
Comprehensive (loss) income attributable to Universal Hospital Services, Inc.	(901)	(573)	(1,268)	(759)
Parent Issuer UHS
Consolidating Financial Statements
Consolidated net (loss) income	(609)	(1,779)	(5,249)	(8,745)
Other comprehensive income:
Gain on minimum pension liability, net of tax	184	488	370	488
Total other comprehensive income	184	488	370	488
Comprehensive (loss) income	(425)	(1,291)	(4,879)	(8,257)
Comprehensive (loss) income attributable to Universal Hospital Services, Inc.	(425)	(1,291)	(4,879)	(8,257)
Subsidiary Guarantor Surgical Services
Consolidating Financial Statements
Consolidated net (loss) income	901	573	1,268	759
Other comprehensive income:
Comprehensive (loss) income	901	573	1,268	759
Comprehensive income attributable to noncontrolling interest	75	95	135	220
Comprehensive (loss) income attributable to Universal Hospital Services, Inc.	$ 826	$ 478	$ 1,133	$ 539

Consolidating Financial State50

Consolidating Financial Statements - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Consolidated net (loss) income	$ (609)	$ (1,779)	$ (5,249)	$ (8,745)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation			36,614	38,315
Asset impairment charges				1,703
Amortization of intangibles, deferred financing costs and bond premium			6,011	6,532
Provision for doubtful accounts			130	54
Provision for inventory obsolescence			86	225
Non-cash share-based compensation expense			1,514	1,140
Gain on sales and disposals of equipment			(1,863)	(2,522)
Deferred income taxes			120	108
Interest on note receivable			(3)
Changes in operating assets and liabilities:
Accounts receivable			(5,301)	(3,980)
Inventories			(80)	(393)
Other operating assets			(1,100)	669
Accounts payable			(1,338)	2,000
Other operating liabilities			(6,537)	5,119
Net cash provided by operating activities			23,004	40,225
Cash flows from investing activities:
Medical equipment purchases			(27,412)	(27,437)
Property and office equipment purchases			(2,083)	(2,433)
Proceeds from disposition of property and equipment			6,944	9,426
Issuance of note receivable from officer			(983)
Acquisition				(2,600)
Net cash used in investing activities			(23,534)	(23,044)
Cash flows from financing activities:
Proceeds under senior secured credit facility			75,700	63,900
Payments under senior secured credit facility			(74,500)	(75,900)
Payments of principal under capital lease obligations			(2,944)	(4,154)
Payment of deferred financing costs			(97)
Holdback payment related to acquisition			(500)
Distributions to noncontrolling interests			(196)	(240)
Contributions from new members to limited liability companies				70
Dividend and equity distribution payments			(24)	(39)
Proceeds from exercise of parent company stock options			66
Change in book overdrafts			3,025	(818)
Net cash provided by (used in) financing activities			530	(17,181)
Consolidating Adjustments
Cash flows from operating activities:
Consolidated net (loss) income	(901)	(573)	(1,268)	(759)
Adjustments to reconcile net loss to net cash provided by operating activities:
Equity in earnings of subsidiary	901	573	1,268	759
Changes in operating assets and liabilities:
Due from affiliates			1,380	1,196
Net cash provided by operating activities			1,380	1,196
Cash flows from financing activities:
Due to affiliates			(1,380)	(1,196)
Net cash provided by (used in) financing activities			(1,380)	(1,196)
Parent Issuer UHS
Cash flows from operating activities:
Consolidated net (loss) income	(609)	(1,779)	(5,249)	(8,745)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation			33,059	34,717
Asset impairment charges				1,703
Amortization of intangibles, deferred financing costs and bond premium			4,304	4,890
Equity in earnings of subsidiary	(901)	(573)	(1,268)	(759)
Provision for doubtful accounts			72	28
Provision for inventory obsolescence			126	210
Non-cash share-based compensation expense			1,514	1,140
Gain on sales and disposals of equipment			(1,903)	(2,436)
Deferred income taxes			799	1,098
Interest on note receivable			(3)
Changes in operating assets and liabilities:
Accounts receivable			(5,110)	(3,213)
Due from affiliates			(1,380)	(1,196)
Inventories			(859)	(410)
Other operating assets			(722)	610
Accounts payable			(522)	1,148
Other operating liabilities			(6,254)	5,788
Net cash provided by operating activities			16,604	34,573
Cash flows from investing activities:
Medical equipment purchases			(22,647)	(25,308)
Property and office equipment purchases			(2,070)	(2,417)
Proceeds from disposition of property and equipment			6,940	9,290
Issuance of note receivable from officer			(983)
Net cash used in investing activities			(18,760)	(18,435)
Cash flows from financing activities:
Proceeds under senior secured credit facility			75,700	63,900
Payments under senior secured credit facility			(74,500)	(75,900)
Payments of principal under capital lease obligations			(2,341)	(3,635)
Payment of deferred financing costs			(97)
Dividend and equity distribution payments			(24)	(39)
Proceeds from exercise of parent company stock options			66
Change in book overdrafts			3,352	(464)
Net cash provided by (used in) financing activities			2,156	(16,138)
Subsidiary Guarantor Surgical Services
Cash flows from operating activities:
Consolidated net (loss) income	$ 901	$ 573	1,268	759
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation			3,555	3,598
Amortization of intangibles, deferred financing costs and bond premium			1,707	1,642
Provision for doubtful accounts			58	26
Provision for inventory obsolescence			(40)	15
Gain on sales and disposals of equipment			40	(86)
Deferred income taxes			(679)	(990)
Changes in operating assets and liabilities:
Accounts receivable			(191)	(767)
Inventories			779	17
Other operating assets			(378)	59
Accounts payable			(816)	852
Other operating liabilities			(283)	(669)
Net cash provided by operating activities			5,020	4,456
Cash flows from investing activities:
Medical equipment purchases			(4,765)	(2,129)
Property and office equipment purchases			(13)	(16)
Proceeds from disposition of property and equipment			4	136
Acquisition				(2,600)
Net cash used in investing activities			(4,774)	(4,609)
Cash flows from financing activities:
Payments of principal under capital lease obligations			(603)	(519)
Holdback payment related to acquisition			(500)
Distributions to noncontrolling interests			(196)	(240)
Contributions from new members to limited liability companies				70
Due to affiliates			1,380	1,196
Change in book overdrafts			(327)	(354)
Net cash provided by (used in) financing activities			$ (246)	$ 153

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Restructuring Reserve [Roll Forward]
Restructuring liability		$ 0.4	$ 2.4	$ 1.6
Payments for Restructuring	$ 1.9	$ 1.1
Other Accrued Expenses
Restructuring Reserve [Roll Forward]
Restructuring liability	$ 0.5

Concentration (Details)

Concentration (Details) - Customer concentration - item	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Concentration
Number of major customers	1	1
Total revenue
Concentration
Concentration risk (as a percent)	16.00%	14.00%